“Real-World Safety Profile of Generic Palbociclib in Hormone Receptor–Positive, HER2-Negative Metastatic Breast Cancer: A Prospective Observational Study in Iraq”” (2026) Journal of Cancer Research Updates, 15(1), pp. 150–155. doi:10.30683/1929-2279.2026.15.13.